Private Portfolio Partners LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 104 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
Private Portfolio Partners LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$644,808
+47.6%
53,600
-20.5%
0.17%
+37.1%
Q3 2022$436,752
+76.6%
67,400
+24.8%
0.12%
+79.7%
Q2 2022$247,366
-32.3%
54,010
+27.8%
0.07%
-23.3%
Q1 2022$365,46342,2500.09%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 576,317$1,504,0001.50%
Phoenix Holdings Ltd. 197,763$483,0000.02%
Frontier Wealth Management LLC 71,900$188,0000.02%
GSA CAPITAL PARTNERS LLP 19,659$51,0000.01%
Rossmore Private Capital 15,061$39,0000.01%
ETF MANAGERS GROUP, LLC 98,486$255,0000.01%
Virtu Financial LLC 10,450$27,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$15,0000.01%
Sterling Investment Advisors, Ltd. 3,150$8,0000.00%
Qube Research & Technologies Ltd 75,395$197,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders